Latest Amyloid precursor protein Stories
Elevated levels of a growth protein in the brains of Alzheimer's disease (AD) patients is linked to impaired neurogenesis, the process by which new neurons are generated.
In people with Alzheimer's, the brain becomes riddled with clumps of protein, forming what are known as amyloid plaques.
In the Sept 9, 2010 issue of Neuron, Neurogenetic Pharmaceuticals, Inc. (NGP) reports proof of concept studies that show its proprietary compound, NGP 555, is effective in preventing the amyloid pathology of Alzheimer's disease (AD) in a transgenic mouse model.
A signaling protein released during rheumatoid arthritis dramatically reduced Alzheimer's disease pathology and reversed the memory impairment of mice bred to develop symptoms of the neurodegenerative disease.
Researchers locate brain passage that could aid early diagnosis.
To view the Social Media Release, click here: http://smr.newswire.ca/en/goexplore-canada/canadas-biggest-travel-app-for-smartphones HALIFAX, July 19 /PRNewswire/ - The producers say goExplore Canada will show you where to go, what to see, where to stay, where to eat and just "where the heck am I?" It's just been released in the Apple app store and will be available in the Android Market around the end of the month. The free app uses detailed maps and includes more than 3,000 Points of...
Researchers from Mayo Clinic's Florida campus say that dementia in some diabetics appears to be caused often by vascular disease in the brain, and the dementia that develops in people without diabetes is more likely associated with deposition of the plaque seen in people with Alzheimer's disease.
HONOLULU, July 14 /PRNewswire-USNewswire/ -- This week, nearly 4,000 scientists from around the world gathered to report and discuss the latest advances in research on treatments, risk factors, and diagnosis for the health epidemic of the 21st century - Alzheimer's disease - at the Alzheimer's Association's 2010 International Conference on Alzheimer's Disease (AAICAD 2010) in Honolulu.
- - New Alzheimer's Risk Gene May Affect Memory Scores and Brain Atrophy in Middle Age - - Clinical Trial of Intranasal Insulin Shows Benefits in Alzheimer's and MCI - - Known Alzheimer's Risk Gene May Change Shape of Brain Deposits - HONOLULU, July 14 /PRNewswire-USNewswire/ -- Last minute scientific submissions to the Alzheimer's Association International Conference on Alzheimer's Disease 2010 (AAICAD 2010) in Honolulu, HI, known as "hot topics," suggest that (1) a newly-discovered risk...
- The act of sweetening by admixture of some saccharine substance.